Sanofi: presents oncology strategy

(CercleFinance.com) - On Tuesday Sanofi presents its strategy in oncology, focusing on four major categories of cancers, with four anchor treatments that the company believes "have the potential to transform patient care".


These four strategic areas are multiple myeloma and skin, lung and breast cancers, respectively. Its four flagship products are Sarclisa, Libtayo, along with two investigational drugs that are being developed.

"We are rapidly building momentum with the execution of our oncology strategy, with several developments on both our pipeline and marketed treatments," said CEO Paul Hudson.


Copyright (c) 2020 CercleFinance.com. All rights reserved.